Combining immunotherapy and radiotherapy in lung cancer: a promising future?

Por Zhou, Jieling, Huang, Qian, Huang, Zijian, Li, Jiqiang
Publicado no J Thorac Dis (2020)

Musashi-2 is a prognostic marker for the survival of patients with cervical cancer

Por Liu, Yaqiong, Fan, Yi, Wang, Xiaoyu, Huang, Zijian, Shi, Kun, Zhou, Bei
Publicado no Oncol Lett (2018)

Circulating Tumor Cells Counting Act as a Potential Prognostic Factor in Cervical Cancer

Por Du, Kunpeng, Huang, Qian, Bu, Junguo, Zhou, Jieling, Huang, Zijian, Li, Jiqiang
Publicado no Technol Cancer Res Treat (2020)

High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma

Por Liu, Yaqiong, Lin, Li, Huang, Zijian, Ji, Bing, Mei, Shanshan, Lin, Ying, Shen, Zhuanxing
Publicado no Int J Clin Exp Pathol (2015)

Homology-mediated end joining-based targeted integration using CRISPR/Cas9

Por Yao, Xuan, Wang, Xing, Hu, Xinde, Liu, Zhen, Liu, Junlai, Zhou, Haibo, Shen, Xiaowen, Wei, Yu, Huang, Zijian, Ying, Wenqin, Wang, Yan, Nie, Yan-Hong, Zhang, Chen-Chen, Li, Sanlan, Cheng, Leping, Wang, Qifang, Wu, Yan, Huang, Pengyu, Sun, Qiang, Shi, Linyu, Yang, Hui
Publicado no Cell Res (2017)